Astrazeneca

Suppression of IRAK1 or IRAK4 Catalytic Activity, but Not Type 1 IFN Signaling, Prevents Lupus Nephritis in Mice Expressing a Ubiquitin Binding–Defective Mutant of ABIN1

P. Cohen, J. Arthur, F. Marchesi, 2016, The Journal of Immunology.